Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-20.4%
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-20.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
20246.18%
2023-9.84%
2022-92.92%
2021-114.74%
202089.70%
201919.35%
2018-47.18%
2017-112.62%
2016-82.18%
2015-0.43%